Tuberc Respir Dis.  2004 Jul;57(1):32-36.

Diagnostic Utility of Pleural Fluid CEA and CYFRA 21-1 for Malignant Pleural Effusions

Affiliations
  • 1Department of Internal Medicine, Kwandong University College of Medicine, Myungji Hospital, Koyang, Korea.
  • 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. sekyukim@yumc.yonsei.ac.kr
  • 3The Institute of Chest Diseases, Yonsei University College of Medicine, Seoul, Korea.
  • 4Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea.
  • 5Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: The purpose of this study was to evaluate the usefulness of the pleural fluid carcinoembryonic antigen (CEA) and cytokeratin fragment 19 (CYFRA 21-1) tumor markers as complementary tools for the diagnosis of malignant pleural effusions.
PATIENTS AND METHODS
The levels of pleural and serum CEA and CYFRA 21-1 were prospectively assayed in 222 patients with pleural effusions (150 benign effusions, 57 bronchogenic carcinomas and 15 metastatic carcinomas).
RESULTS
The levels of pleural fluid CEA and CYFRA 21-1 in the malignant effusions were significantly higher than those in the benign effusions. With a specificity of 95%, the cut off values for the CEA and CYFRA 21-1 in pleural effusions were 5 and 89 ng/ml, respectively. The diagnostic sensitivities of the pleural fluid CEA and CYFRA 21-1 in malignant effusions were 72 and 54%, respectively, whereas using a combination of the two, the sensitivity increased to 87% (p<0.05).
CONCLUSIONS
: These findings suggest that a combination of the pleural fluid CEA and CYFRA 21-1 in pleural effusions can be useful in the diagnosis of malignant pleural effusions.

Keyword

CEA; CYFRA 21-1; Malignant pleural effusions

MeSH Terms

Carcinoembryonic Antigen
Carcinoma, Bronchogenic
Diagnosis
Humans
Keratins
Pleural Effusion
Pleural Effusion, Malignant*
Prospective Studies
Biomarkers, Tumor
Carcinoembryonic Antigen
Keratins
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr